Cell fusion enhances mesendodermal differentiation of human induced pluripotent stem cells

Stem Cells and Development

Volumn 23, Issue 23, 2014, Pages 2875-2882

  Qin, Jie ^a,b   Sontag, Stephanie ^a,b   Lin, Qiong ^a,b   Mitzka, Saskia ^a,b   Leisten, Isabelle ^c   Schneider, Rebekka K ^c   Wang, Xiaoying ^a,b   Jauch, Anna ^d   Peitz, Michael ^e   Brüstle, Oliver ^e   Wagner, Wolfgang ^b   Zhao, Robert Chunhua ^f,g   Zenke, Martin ^a,b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^g PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ALPHA FETOPROTEIN; BRACHYURY PROTEIN; GOOSECOID PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; MYOSIN HEAVY CHAIN ALPHA; PROTEIN; PROTEIN MIXL1; PROTEIN NODAL; SMAD PROTEIN; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN;

ARTICLE; CELL DIFFERENTIATION; CELL FUSION; CELL LINEAGE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GERM LAYER; GLYCOGEN SYNTHESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYBRID CELL; INTRACELLULAR SIGNALING; MESENDODERM; PLURIPOTENT STEM CELL; PRIMITIVE STREAK; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL CULTURE; UPREGULATION; BIOSYNTHESIS; CYTOLOGY; MESODERM; METABOLISM;

ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL FUSION; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESODERM;

EID: 84911370464     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0120     Document Type: Article

References (39)

1. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
2. Saha K and R Jaenisch. (2009). Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5:584-595.
3. Yamanaka S and HM Blau. (2010). Nuclear reprogramming to a pluripotent state by three approaches. Nature 465:704-712.
4. Bellin M, MC Marchetto, FH Gage and CL Mummery. (2012). Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol 13:713-726.
5. Robinton DA and GQ Daley. (2012). The promise of induced pluripotent stem cells in research and therapy. Nature 481:295-305.
6. Feng Q, SJ Lu, I Klimanskaya, I Gomes, D Kim, Y Chung, GR Honig, KS Kim and R Lanza. (2010). Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28:704-712.
7. Narsinh KH, N Sun, V Sanchez-Freire, AS Lee, P Almeida, S Hu, T Jan, KD Wilson, D Leong, et al. (2011). Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest 121:1217-1221.
8. Mummery CL, J Zhang, ES Ng, DA Elliott, AG Elefanty and TJ Kamp. (2012). Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 111:344-358.
9. Cowan CA, J Atienza, DA Melton and K Eggan. (2005). Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309:1369-1373.
10. Hasegawa K, P Zhang, Z Wei, JE Pomeroy, W Lu and MF Pera. (2010). Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion. Stem Cells 28:1338-1348.
11. Yu J, MA Vodyanik, P He, Slukvin, II and JA Thomson. (2006). Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion. Stem Cells 24:168-176.
12. Han DW, JT Do, L Gentile, M Stehling, HT Lee and HR Schö ler. (2008). Pluripotential reprogramming of the somatic genome in hybrid cells occurs with the first cell cycle. Stem Cells 26:445-454.
13. Do JT, HW Choi, Y Choi and HR Schöler. (2011). Pluripotent hybrid cells contribute to extraembryonic as well as embryonic tissues. Stem Cells Dev 20:1063-1069.
14. Tada M, Y Takahama, K Abe, N Nakatsuji and T Tada. (2001). Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11:1553-1558.
15. Tat PA, H Sumer, D Pralong and PJ Verma. (2011). The efficiency of cell fusion-based reprogramming is affected by the somatic cell type and the in vitro age of somatic cells. Cell Reprogram 13:331-344.
16. Foshay KM, TJ Looney, S Chari, FF Mao, JH Lee, L Zhang, CJ Fernandes, SW Baker, KL Clift, et al. (2012). Embryonic stem cells induce pluripotency in somatic cell fusion through biphasic reprogramming. Mol Cell 46:159-170.
17. Pereira CF, FM Piccolo, T Tsubouchi, S Sauer, NK Ryan, L Bruno, D Landeira, J Santos, A Banito, et al. (2010). ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency. Cell Stem Cell 6:547-556.
18. Bhutani N, JJ Brady, M Damian, A Sacco, SY Corbel and HM Blau. (2010). Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463: 1042-1047.
19. Tsubouchi T, J Soza-Ried, K Brown, FM Piccolo, I Cantone, D Landeira, H Bagci, H Hochegger, M Merkenschlager and AG Fisher. (2013). DNA synthesis is required for reprogramming mediated by stem cell fusion. Cell 152: 873-883.
20. Do JT and HR Schöler. (2004). Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 22:941-949.
21. Matveeva NM, AG Shilov, EM Kaftanovskaya, LP Maximovsky, AI Zhelezova, AN Golubitsa, SI Bayborodin, MM Fokina and OL Serov. (1998). In vitro and in vivo study of pluripotency in intraspecific hybrid cells obtained by fusion of murine embryonic stem cells with splenocytes. Mol Reprod Dev 50:128-138.
22. Pralong D, ML Lim, I Vassiliev, K Mrozik, N Wijesundara, P Rathjen and PJ Verma. (2005). Tetraploid embryonic stem cells contribute to the inner cell mass of mouse blastocysts. Cloning Stem Cells 7:272-278.
23. Jentsch I, J Geigl, CA Klein and MR Speicher. (2003). Seven-fluorochrome mouse M-FISH for high-resolution analysis of interchromosomal rearrangements. Cytogenet Genome Res 103:84-88.
24. Dahl JA and P Collas. (2008). A rapid micro chromatin immunoprecipitation assay (microChIP). Nat Protoc 3:1032-1045.
25. Koch P, T Opitz, JA Steinbeck, J Ladewig and O Brüstle. (2009). A rosette-type, self-renewing human ES cellderived neural stem cell with potential for in vitro instruction and synaptic integration. Proc Natl Acad Sci USA 106: 3225-3230.
26. Weidgang CE, R Russell, PR Tata, SJ Kuhl, A Illing, M Müller, Q Lin, C Brunner, TM Boeckers, et al. (2013). TBX3 directs cell-fate decision toward mesendoderm. Stem Cell Rep 1:248-265.
27. Finger JH, CM Smith, TF Hayamizu, IJ McCright, JT Eppig, JA Kadin, JE Richardson and M Ringwald. (2011). The mouse Gene Expression Database (GXD): 2011 update. Nucleic Acids Res 39:D835-D841.
28. Hirst CE, ES Ng, L Azzola, AK Voss, T Thomas, EG Stanley and AG Elefanty. (2006). Transcriptional profiling of mouse and human ES cells identifies SLAIN1, a novel stem cell gene. Dev Biol 293:90-103.
29. Murry CE and G Keller. (2008). Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132:661-680.
30. Xi Q, Z Wang, AI Zaromytidou, XH Zhang, LF Chow-Tsang, JX Liu, H Kim, A Barlas, K Manova-Todorova, et al. (2011). A poised chromatin platform for TGF-beta access to master regulators. Cell 147:1511-1524.
31. Massague J and Q Xi. (2012). TGF-beta control of stem cell differentiation genes. FEBS Lett 586:1953-1958.
32. Munoz-Sanjuan I and AH Brivanlou. (2002). Neural induction, the default model and embryonic stem cells. Nat Rev Neurosci 3:271-280.
33. Tam PP and DA Loebel. (2007). Gene function in mouse embryogenesis: get set for gastrulation. Nat Rev Genet 8: 368-381.
34. Polo JM, S Liu, ME Figueroa, W Kulalert, S Eminli, KY Tan, E Apostolou, M Stadtfeld, Y Li, et al. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28:848-855.
35. Ohi Y, H Qin, C Hong, L Blouin, JM Polo, T Guo, Z Qi, SL Downey, PD Manos, et al. (2011). Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 13:541-549.
36. Hussein SM, NN Batada, S Vuoristo, RW Ching, R Autio, E Narva, S Ng, M Sourour, R Hamalainen, et al. (2011). Copy number variation and selection during reprogramming to pluripotency. Nature 471:58-62.
37. Cahan P and GQ Daley. (2013). Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol 14:357-368.
38. Ying QL, J Nichols, EP Evans and AG Smith. (2002). Changing potency by spontaneous fusion. Nature 416:545-548.
39. Nagy A, E Gocza, EM Diaz, VR Prideaux, E Ivanyi, M Markkula and J Rossant. (1990). Embryonic stem cells alone are able to support fetal development in the mouse. Development 110:815-821.